in partnership with
DRC Logo
News/ Press Release

Retina Foundation Presents at Largest Retina Meeting in China

Retina China 2018, a prestigious meeting held March 28-30 in Qingdao, China, was well attended by retinal specialists from all over Asia with only a handful invited from the United States, including Dr. Karl Csaky, Managing & Medical Director of the Retina Foundation of the Southwest. Having been invited to present at this meeting, Dr. Csaky used this opportunity to speak about the new OCT-A machine recently acquired by the Retina Foundation. This new cutting-edge technology enables our researchers to obtain detailed information on the retinal layers, blood vessels, blood flow, and more in patients with age-related macular degeneration. Dr. Csaky’s talk highlighted the importance of this new technology in helping diagnose and treat patients with age-related macular degeneration.

About Dr. Karl G. Casky

Karl G. Csaky, M.D., Ph.D. is the Managing & Medical Director, Director of the Molecular Ophthalmology Laboratory, and the T. Boone Pickens Senior Scientist at the Retina Foundation of the Southwest. Dr. Csaky’s main area of research is age-related macular degeneration, on which he conducts both laboratory and clinical research.

About Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the number one cause of vision loss for people over the age of 65. It is a common retinal disease that disrupts the central vision that is necessary for everyday tasks such as reading, writing, and driving. Age-related macular degeneration occurs when there is a loss of visual cells (rods and cones) from the macula, the central part of the retina.

Retina Foundation Presents at Largest Retina Meeting in China

Related Articles

Chance Encounter Leads to Early Diagnosis and Treatment for Kate The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust grants Retina Foundation $133,000 for Genetic Eye Disease International Partnership for Lazy Eye Detection and Treatment New Technology Gives ‘Second Sight’ to the Blind iPad App for Detecting Retinal Disease Receives Second FDA Approval
Mailicon
Get the Latest Updates

Sign up to receive emails from Retina Foundation that will keep you up-to-date on our research and events.

  • This field is for validation purposes and should be left unchanged.
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.
x

Please check all that apply:

How did you learn about the
Retina Foundation?

  • Please check all that apply:
  • This field is for validation purposes and should be left unchanged.
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form